Drug Profile


Alternative Names: Glycerol monolaurate; Glylorin; T 100

Latest Information Update: 07 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cellegy Pharmaceuticals
  • Class Anti-inflammatories; Antipruritics; Glycerides; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Atopic dermatitis; Congenital ichthyosiform erythroderma; Ichthyosis; Impetigo

Most Recent Events

  • 31 Dec 2006 Discontinued - Phase-II for Ichthyosis in USA (Topical)
  • 31 Dec 2006 Discontinued - Phase-III for Congenital ichthyosiform erythoderma in USA (unspecified route)
  • 13 Mar 2001 Discontinued-I for Impetigo in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top